Reportlinker Adds The Top 10 Orthopedic Device Companies: Financial performance, research activities, and growth strategies

NEW YORK, Sept. 7  /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

The Top 10 Orthopedic Device Companies: Financial performance, research activities, and growth strategies

http://www.reportlinker.com/p0289100/The-Top-10-Orthopedic-Device-Companies-Financial-performance-research-activities-and-growth-strategies.html

The orthopedic device industry is highly competitive and has reached maturity, as demonstrated by its single digit growth rate. The industry is driven largely by incremental innovation and breakthrough product launches have stalled. Several product lines are also facing severe commoditization due to increased competition. Despite such high levels of competition, the top 15 companies accounted for 95% of the market in 2009. The largest device segments are spinal, knee, and hip implants. The fastest growing segment is orthobiologics.

The report provides detailed profiles of the top 10 orthopedic device companies and brief profiles of five other major players. It elucidates trends associated with companies that develop, manufacture, and market orthopedic devices. Detailed profiles contain descriptions of products, financial performance, and growth strategies together with SWOT analyses. For each company analysis is based on:

• Each company's consolidated and segmental financial performance;
• Each company's growth strategies and major acquisitions and divestments relating to the CV devices market;
• Key partnerships and alliances formed by these companies;
• Business-related strengths and weaknesses of these companies, and insights into the opportunities and threats facing them.

Key drivers and resistors to growth of leading CV device companies.

Drivers

• Demographics – aging population
• Preference for biologic implants increasing
• Growth in emerging markets
• Physician preferences boosted by CME programs
• Continued innovation

Resistors

• Increasing pricing pressure from buyers and payers
• Rising usage of comparative efficacy and health economics data
• Regulatory demand for postmarketing surveillance
• Review of the PMN pathway in the US
• Medical device excise tax amounting to $20bn over the next 20 years

Key benefits of reading this report

• Learn from the business operation strategies of the premier orthopedic device companies to target future growth markets effectively, avoid their mistakes, and replicate their successes.
• Benchmark your performance against the leading orthopedic device companies.
• Analyze the growth strategies of major players in the orthopedic industry and learn how their business models are planned for the next 3 to 5 years .
• Compare performances of the top 10 companies in the orthopedic market with respect to acquisitions, new product innovation, geography expansion, and industry challenges.
• Save time, money, and resources on analyzing the performance of leading orthopedic device companies using this report.

Key findings from this report

• The global orthopedic market had an estimated $33bn size in 2009, a Y-o-Y increase of 7.1%. The market is moderately dependent on macroeconomic trends and demographics.
• In 2009, the market growth was adversely affected by patient deferral of orthopedic procedures and increased pricing pressure from buyers. Market performance was also considerably impacted by currency fluctuations, owing to a strengthening US dollar. This is due to the fact that majority of orthopedic companies are based in the US.
• Spine, knee, and hip implants formed the largest orthopedic market segments in 2009, and accounted for nearly $18.2bn sales. Surgical accessories used in orthopedic procedures represent the most fragmented market segment, followed by spinal devices. The orthobiologics segment has the least competition and was also fastest growing segment.
• Regulatory pressure on the orthopedic market will significantly rise due to the impending review of the PMN pathway, the Physician Payment Sunshine Act and application of comparative effectiveness research (CER) information by buyers and payers.
• Along with CER studies, the impending $20bn medical device tax will add further pricing pressures.

Key questions answered by this report

• What was the market value of the global orthopedic device industry in 2009?
• What are the global market values for the major orthopedic device segments?
• What are the key trends observed in the orthopedic device companies and what are the strategic responses that are taking shape?
• Who are the major players in the global orthopedic device market?
• What are the growth strategies of the leading orthopedic device companies?
• What are the strengths, weaknesses, opportunities and threats faced by the top 10 players?

Table of Contents

About Business Insights 2

Disclaimer 2

Executive summary 11

Industry overview 11

Stryker 11

DePuy 12

Zimmer 12

Medtronic 13

Synthes 13

Smith & Nephew 14

Biomet 14

Orthofix 14

Wright Medical Group 15

Conmed 15

Chapter 1 Introduction 17

What is this report about? 17

Methodology 17

Chapter 2 Industry overview 18

Summary 18

Introduction 18

Market segmentation 20

Competitive landscape 21

Key drivers and resistors 22

Key events and trends 23

Changes in the PMN pathway will increase regulatory burden 23

CME platforms will continue to drive growth despite the Department of Justice (DOJ) clampdown 24

CME and inducements 24

DOJ settlement with device manufacturers 25

Physician Sunshine Act may stifle innovation in the orthopedic device industry 27

Impact of decline in hospital capital expenditure on orthopedics minimal in the near term 28

Medical device industry bracing for the comparative effectiveness research (CER) era 29

Medical device excise tax will influence orthopedic market top line 30

Rising regulatory pressure on spinal device makers 30

Chapter 3 Stryker 31

Summary 31

Company overview 31

Marketed products 32

Orthopedic implants 32

MedSurg equipment 32

Financial performance 32

Orthopedic implants 34

Hip implant systems 34

Knee implant systems 34

Trauma implant systems 34

Spinal implant systems 35

Craniomaxillofacial implant systems 35

MedSurg equipments 35

Surgical equipment and surgical navigation systems 35

Endoscopic and communications systems 35

Research and innovation 36

Growth strategy 36

SWOT 38

Chapter 4 DePuy 39

Summary 39

Company overview 39

Marketed products 40

DePuy Orthopedics 40

DePuy Spine 40

DePuy Mitek 40

Codman & Shurtleff 40

Financial performance 41

Research and product launches 42

Growth strategy 42

SWOT 44

Chapter 5 Zimmer 45

Summary 45

Company overview 45

Marketed products 45

Reconstructive 45

Dental 46

Trauma 46

Spine 46

OSP 46

Financial performance 46

Reconstructive 48

Knee 48

Hip 48

Extremities 49

Dental 49

Trauma 49

Spine 49

OSP 49

Research and innovation 49

Growth strategy 50

SWOT 52

Chapter 6 Medtronic 53

Summary 53

Company overview 53

Marketed products 54

Financial performance 54

Core spinal 55

Biologics 56

Research and innovation 56

Growth strategy 57

SWOT 58

Chapter 7 Synthes 59

Summary 59

Company overview 59

Marketed products 59

Trauma 59

Spine 60

CMF 60

Financial performance 60

Research and innovation 62

Growth strategy 62

SWOT 64

Chapter 8 Smith & Nephew 65

Summary 65

Company overview 65

Marketed products 66

Orthopedics 66

Endoscopy 66

Financial performance 66

Orthopedics 68

Endoscopy 68

Research and innovation 68

Growth strategy 69

SWOT 70

Chapter 9 Biomet 71

Summary 71

Company overview 71

Marketed products 71

Reconstructive products 71

Fixation devices 72

Spinal products 72

Other 72

Financial performance 72

Research and innovation 74

Growth strategy 74

SWOT 76

Chapter 10 Orthofix 77

Summary 77

Company overview 77

Marketed products 78

Spinal products 78

Orthopedic products 78

Sports medicine 78

Financial performance 78

Spine 80

Orthopedics 80

Sports medicine 80

Research and innovation 80

Growth strategies 80

SWOT 82

Chapter 11 Wright Medical Group 83

Summary 83

Company overview 83

Marketed products 83

Hip products 83

Knee products 83

Extremity products 84

Biologics products 84

Financial performance 84

Hip products 86

Knee products 86

Extremity products 86

Biologic products 86

Research and innovation 86

Growth strategy 87

SWOT 88

Chapter 12 Conmed 89

Summary 89

Company overview 89

Marketed products 89

Arthroscopy 89

Powered surgical instruments 90

Financial performance 90

Arthroscopy 92

Powered surgical equipments 92

Research and innovation 92

Growth strategy 92

SWOT 93

Chapter 13 Other major companies 94

NuVasive 94

Integra LifeSciences 95

Arthrocare 96

Exactech 98

RTI Biologics 99

Appendix 101

Abbreviations 101

Table of figures

Figure 1: Orthopedic device global market performance, 2007–09 20

Figure 2: Key drivers and resistors of the orthopedic market 24

Figure 3: Effect of the Physician Payment Sunshine Act on the orthopedic market competitive

landscape 28

Figure 4: Stryker's financial performance, 2007–2009 33

Figure 5: Stryker – SWOT 38

Figure 6: DePuy's financial performance, 2007–2009 42

Figure 7: DePuy – SWOT 44

Figure 8: Zimmer's financial performance, 2007–2009 47

Figure 9: Zimmer – SWOT 52

Figure 10: Financial performance Medtronic's spinal business, 2007–2009 55

Figure 11: Medtronic – SWOT 58

Figure 12: Synthes' financial performance, 2007–2009 61

Figure 13: Synthes – SWOT 64

Figure 14: Smith & Nephew's financial performance, 2007–2009 67

Figure 15: Smith & Nephew – SWOT 70

Figure 16: Biomet's financial performance, 2007–2009 73

Figure 17: Biomet – SWOT 76

Figure 18: Financial performance of Orthofix's orthopedic operations, 2007–2009 79

Figure 19: Orthofix – SWOT 82

Figure 20: Wright Medical Group's financial performance, 2007–2009 85

Figure 21: Wright Medical Group - SWOT 88

Figure 22: Financial performance of Conmed's orthopedic operations, 2007–2009 91

Figure 23: Conmed – SWOT 93

Figure 24: NuVasive's financial performance, 2007–2009 95

Figure 25: Financial performance of Integra LifeScience's orthopedic business, 2007–2009 96

Figure 26: Financial performance of Arthrocare's orthopedic business, 2007–2009 98

Figure 27: Exactech's financial performance, 2007–2009 99

Figure 28: Financial performance of RTI Biologic's orthopedic business, 2007–2009 100

Table of tables

Table 1: Orthopedic device global market performance, 2007–09 19

Table 2: Global market sizes of orthopedic device segments, 2009 21

Table 3: Market shares of top 15 orthopedic device companies, 2007–09 22

Table 4: Orthopedic companies and surgeon/resident training programs 25

Table 5: Settlements by orthopedic players to US DOJ 26

Table 6: Stryker's financial performance, 2007–2009 32

Table 7: Financial performance of Stryker's business units, 2008–2009 34

Table 8: DePuy's financial performance, 2007–2009 41

Table 9: Zimmer's financial performance, 2007–2009 47

Table 10: Financial performance of Zimmer's business units, 2008–2009 48

Table 11: Financial performance Medtronic's spinal business, 2007–2009 54

Table 12: Financial performance of Medtronic's spinal business units, 2008–2009 55

Table 13: Synthes' financial performance, 2007–2009 60

Table 14: Smith & Nephew's financial performance, 2007–2009 66

Table 15: Financial performance of Smith & Nephew's business units, 2008–2009 67

Table 16: Biomet's financial performance, 2007–2009 73

Table 17: Financial performance of Biomet's business units, 2008–09 74

Table 18: Financial performance of Orthofix's orthopedic operations, 2007–2009 78

Table 19: Performance of Orthofix's orthopedic product lines, 2008–2009 79

Table 20: Wright Medical Group's financial performance, 2007–2009 84

Table 21: Performance of Wright Medical Group's orthopedic product lines, 2008-2009 85

Table 22: Financial performance of Conmed's orthopedic operations, 2007–2009 90

Table 23: Performance of Conmed Linvatec's product lines, 2009 91

Table 24: NuVasive's financial performance, 2007–2009 94

Table 25: Financial performance of Integra LifeScience's orthopedic business, 2007–2009 96

Table 26: Financial performance of Arthrocare's orthopedic business, 2007–2009 97

Table 27: Exactech's financial performance, 2007–2009 99

Table 28: Financial performance of RTI Biologic's orthopedic business, 2007–2009 100

To order this report:  

Orthopedic Industry: The Top 10 Orthopedic Device Companies: Financial performance, research activities, and growth strategies

Orthopedic Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

SOURCE Reportlinker

21%

more press release views with 

Request a Demo